Pegfilgrastim vs. filgrastim in reducing risk of febrile neutropenia.

被引：0
|
作者：
Lyman, GH
Bernal, M
Badamgarav, E
Pinto, L
Dubois, RW
机构：
[1] Univ Rochester, Dept Med, Rochester, NY 14627 USA
[2] Zynx Hlth Inc, Beverly Hills, CA USA
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4393
引用
收藏
页码：170B / 171B
页数：2
相关论文
共 50 条
  • [21] Validation of a risk model for hospitalized adult cancer patients with febrile neutropenia.
    Kuderer, NM
    Crawford, J
    Dale, DC
    Lyman, GH
    BLOOD, 2004, 104 (11) : 29A - 29A
  • [22] Cefepime in febrile patients with chemotherapy induced neutropenia.
    Varthalitis, I
    Athanassiou, A
    Papadopoulou, M
    Vlachopoulos, V
    Christakis, G
    Pectassides, D
    ANNALS OF ONCOLOGY, 2000, 11 : 150 - 150
  • [23] A single dose of pegfilgrastim reduces the incidence of febrile neutropenia in various risk strata compared with daily filgrastim following myelosuppressive chemotherapy.
    Shogan, JE
    Koelbl, H
    Holmes, FA
    Liang, B
    Hackett, J
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S134 - S134
  • [24] Cost of chemotherapy-related febrile neutropenia.
    Weycker, D.
    Malin, J.
    Glass, A.
    Oster, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 317S - 317S
  • [25] Cost-efficiency analyses for the US of biosimilar filgrastim-sndz, reference filgrastim, pegfilgrastim, and pegfilgrastim with on-body injector in the prophylaxis of chemotherapy-induced (febrile) neutropenia
    McBride, Ali
    Campbell, Kim
    Bikkina, Mohan
    MacDonald, Karen
    Abraham, Ivo
    Balu, Sanjeev
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (10) : 1083 - 1093
  • [26] Cost-effectiveness of pegfilgrastim versus six days of filgrastim for preventing febrile neutropenia in breast cancer patients
    Danova, Marco
    Chiroli, Silvia
    Rosti, Giovanni
    Doan, Quan V.
    TUMORI JOURNAL, 2009, 95 (02): : 219 - 226
  • [27] Pegfilgrastim (Neulasta®) Vs. Tbo-Filgrastim (Granix®) Post Autologous Transplant
    Schmidt, Sarah
    Newman, Katherine
    Machiorlatti, Michael
    Vesely, Sara K.
    Chakrabarty, Jennifer Holter
    Selby, George B.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S280 - S281
  • [28] Early pegfilgrastim reduces febrile neutropenia in elderly
    Reactions Weekly, 2005, 1053 (1) : 5 - 5
  • [29] Incidence of febrile neutropenia during chemotherapy among patients with nonmyeloid cancer receiving filgrastim vs a filgrastim biosimilar
    Schwartzberg, Lee S.
    Lal, Lincy S.
    Balu, Sanjeev
    Campbell, Kim
    Brekke, Lee
    Elliott, Caitlin
    Korrer, Stephanie
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2018, 10 : 493 - 500
  • [30] Reply: Cost-efficiency analyses for the US of biosimilar filgrastim-sndz, reference filgrastim, pegfilgrastim, and pegfilgrastim with on-body injector in the prophylaxis of chemotherapy-induced (febrile) neutropenia
    McBride, Ali
    Campbell, Kim
    Bikkina, Mohan
    MacDonald, Karen
    Abraham, Ivo
    Balu, Sanjeev
    JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (06) : 606 - 609
12345